Where it's made
McPherson, KS, United States · makes it, tests it, packages it and labels it
Problems found, fixed voluntarily Last FDA inspection Jan 17, 2025. 16 inspections on record, 2 with serious problems.
Recalls
- Dec 22, 2022 · Class I · Terminated
Presence of Particulate Matter: Glass particulate matter detected in injectable.
Lots: Lot: 33045BA, EXP 1SEP2023
- Aug 30, 2017 · Class I · Terminated
Presence of Particulate Matter: glass particulate found in vial
Lots: Lot: 632153A; Exp. 03/18
- Nov 7, 2014 · Class III · Terminated
Correct Labeled Product Mispack: Product tray containing vials was mislabeled to contain another product.
Lots: Lot# 43-240-DD; Exp. 07/16 Lot# 44-205-DD,44-455-DD,44-460-DD,44-465-DD; Exp. 08/16
- Oct 6, 2014 · Class II · Terminated
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Lots: One shipment of Lot #: 34-366-8E02; Exp 1OCT2015 to The Harvard Drug Group, Livonia, MI
- Oct 6, 2014 · Class II · Terminated
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Lots: Lot #: 35-315-DD; Exp 1NOV2015
Product details
- Generic drug
- Vancomycin: see every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 1 g
- Approval
- ANDA ANDA062912
- On the market since
- Feb 18, 2020
- Package NDCs
0409-6533-31 0409-6533-59 - Official label
- DailyMed (National Library of Medicine), updated Apr 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?